Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash 88 tok/s
Gemini 2.5 Pro 54 tok/s Pro
GPT-5 Medium 18 tok/s
GPT-5 High 27 tok/s Pro
GPT-4o 97 tok/s
GPT OSS 120B 451 tok/s Pro
Kimi K2 212 tok/s Pro
2000 character limit reached

Free-form tumor synthesis in computed tomography images via richer generative adversarial network (2104.09701v1)

Published 20 Apr 2021 in eess.IV and cs.CV

Abstract: The insufficiency of annotated medical imaging scans for cancer makes it challenging to train and validate data-hungry deep learning models in precision oncology. We propose a new richer generative adversarial network for free-form 3D tumor/lesion synthesis in computed tomography (CT) images. The network is composed of a new richer convolutional feature enhanced dilated-gated generator (RicherDG) and a hybrid loss function. The RicherDG has dilated-gated convolution layers to enable tumor-painting and to enlarge perceptive fields; and it has a novel richer convolutional feature association branch to recover multi-scale convolutional features especially from uncertain boundaries between tumor and surrounding healthy tissues. The hybrid loss function, which consists of a diverse range of losses, is designed to aggregate complementary information to improve optimization. We perform a comprehensive evaluation of the synthesis results on a wide range of public CT image datasets covering the liver, kidney tumors, and lung nodules. The qualitative and quantitative evaluations and ablation study demonstrated improved synthesizing results over advanced tumor synthesis methods.

Citations (38)
List To Do Tasks Checklist Streamline Icon: https://streamlinehq.com

Collections

Sign up for free to add this paper to one or more collections.

Summary

We haven't generated a summary for this paper yet.

Ai Generate Text Spark Streamline Icon: https://streamlinehq.com

Paper Prompts

Sign up for free to create and run prompts on this paper using GPT-5.

Dice Question Streamline Icon: https://streamlinehq.com

Follow-up Questions

We haven't generated follow-up questions for this paper yet.